Medigen Vaccine Biologics Statistics
Total Valuation
TPEX:6547 has a market cap or net worth of TWD 12.54 billion. The enterprise value is 11.14 billion.
Market Cap | 12.54B |
Enterprise Value | 11.14B |
Important Dates
The next estimated earnings date is Thursday, November 13, 2025.
Earnings Date | Nov 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TPEX:6547 has 328.75 million shares outstanding. The number of shares has increased by 0.03% in one year.
Current Share Class | 328.75M |
Shares Outstanding | 328.75M |
Shares Change (YoY) | +0.03% |
Shares Change (QoQ) | +0.00% |
Owned by Insiders (%) | 0.29% |
Owned by Institutions (%) | 3.38% |
Float | 252.72M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 19.84 |
PB Ratio | 3.42 |
P/TBV Ratio | 3.44 |
P/FCF Ratio | n/a |
P/OCF Ratio | 337.80 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -78.72 |
EV / Sales | 17.63 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -3,096.61 |
Financial Position
The company has a current ratio of 13.70, with a Debt / Equity ratio of 0.08.
Current Ratio | 13.70 |
Quick Ratio | 10.50 |
Debt / Equity | 0.08 |
Debt / EBITDA | 45.15 |
Debt / FCF | -85.53 |
Interest Coverage | -15.02 |
Financial Efficiency
Return on equity (ROE) is -3.77% and return on invested capital (ROIC) is -2.03%.
Return on Equity (ROE) | -3.77% |
Return on Assets (ROA) | -1.95% |
Return on Invested Capital (ROIC) | -2.03% |
Return on Capital Employed (ROCE) | -3.32% |
Revenue Per Employee | 6.14M |
Profits Per Employee | -1.37M |
Employee Count | 103 |
Asset Turnover | 0.15 |
Inventory Turnover | 0.50 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.20% in the last 52 weeks. The beta is 0.96, so TPEX:6547's price volatility has been similar to the market average.
Beta (5Y) | 0.96 |
52-Week Price Change | -13.20% |
50-Day Moving Average | 39.35 |
200-Day Moving Average | 44.68 |
Relative Strength Index (RSI) | 43.87 |
Average Volume (20 Days) | 755,922 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6547 had revenue of TWD 632.12 million and -141.54 million in losses. Loss per share was -0.43.
Revenue | 632.12M |
Gross Profit | 387.19M |
Operating Income | -131.40M |
Pretax Income | -141.54M |
Net Income | -141.54M |
EBITDA | -11.07M |
EBIT | -131.40M |
Loss Per Share | -0.43 |
Balance Sheet
The company has 1.71 billion in cash and 307.75 million in debt, giving a net cash position of 1.40 billion or 4.26 per share.
Cash & Cash Equivalents | 1.71B |
Total Debt | 307.75M |
Net Cash | 1.40B |
Net Cash Per Share | 4.26 |
Equity (Book Value) | 3.67B |
Book Value Per Share | 11.15 |
Working Capital | 2.27B |
Cash Flow
In the last 12 months, operating cash flow was 37.13 million and capital expenditures -40.73 million, giving a free cash flow of -3.60 million.
Operating Cash Flow | 37.13M |
Capital Expenditures | -40.73M |
Free Cash Flow | -3.60M |
FCF Per Share | -0.01 |
Margins
Gross margin is 61.25%, with operating and profit margins of -20.79% and -22.39%.
Gross Margin | 61.25% |
Operating Margin | -20.79% |
Pretax Margin | -22.39% |
Profit Margin | -22.39% |
EBITDA Margin | -1.75% |
EBIT Margin | -20.79% |
FCF Margin | n/a |
Dividends & Yields
TPEX:6547 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.03% |
Shareholder Yield | n/a |
Earnings Yield | -1.13% |
FCF Yield | -0.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on August 3, 2022. It was a forward split with a ratio of 1.48280574.
Last Split Date | Aug 3, 2022 |
Split Type | Forward |
Split Ratio | 1.48280574 |
Scores
TPEX:6547 has an Altman Z-Score of 19.99 and a Piotroski F-Score of 4.
Altman Z-Score | 19.99 |
Piotroski F-Score | 4 |